Date: October 12, 2022
Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST)
Throughout drug development, it is important to characterize and quantify pharmaceutical compounds and any associated metabolites to ensure proper drug safety and efficacy. LC-MS/MS techniques are predominantly used for such analyses because they provide a comprehensive outlook and can offer a sensitive and selective approach for the quantification of compounds. However, limited deep fragment coverage and sensitivity challenge the confident identification and quantification of metabolites and drug products. Here, alternative fragmentation paired with a highly sensitive QTOF system was employed for comprehensive data collection to properly identify metabolites and quantify complex peptide therapeutics.
- Easily identify critical metabolites for drug discovery with the application of a diagnostic fragmentation technique
- Enrich data collection with the sensitive approach of the latest generation QTOF technology for comprehensive metabolite analysis
- Perform sensitive and selective quantification using alternative fragmentation of complex peptide structures with disulfide bridging
Webinars will be available for unlimited on-demand viewing after live event.